Stay updated on CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide NIH notice was added, informing visitors about a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition.SummaryDifference1%

- Check16 days agoChange DetectedThe site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous detailed study content with a generic error page.SummaryDifference21%

- Check64 days agoChange DetectedThe page shows a new revision label, updating from v3.6.5 to v3.6.6, indicating a software update on the site.SummaryDifference0.1%

Stay in the know with updates to CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.